Forum Topic Biotechnology
  • Conversation: Dx Reimbursement Outlook Symposium in San Francisco

    • February 13, 2019 1:48 AM GMT
      • Post(s)

      Dx Reimbursement Outlook Symposium in San Francisco

      Achieving commercial success for an IVD product or an LDT assay is becoming progressively more difficult in the current healthcare environment. The combination of tightening budgets and the launch of a large number of expensive molecular tests creates complications for payers to respond in traditional ways. Cambridge Healthtech Institute’s 2nd Annual Dx Reimbursement Outlook symposium will provide its participants with a unique opportunity to discuss winning strategies with government and private payers as well as with their peers who are working on similar tasks.

Add Reputation

Do you want to add reputation for this member by this post?

or cancel